127 related articles for article (PubMed ID: 16923520)
1. Severe hematological side effects following Rituximab therapy in children.
Larrar S; Guitton C; Willems M; Bader-Meunier B
Haematologica; 2006 Aug; 91(8 Suppl):ECR36. PubMed ID: 16923520
[TBL] [Abstract][Full Text] [Related]
2. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.
Rao A; Kelly M; Musselman M; Ramadas J; Wilson D; Grossman W; Shenoy S
Pediatr Blood Cancer; 2008 Apr; 50(4):822-5. PubMed ID: 17570702
[TBL] [Abstract][Full Text] [Related]
3. Severe neutropenia and thrombocytopenia following cardiac transplantation in a child.
Chitlur M; Abella E; Singh TP; Savaşan S
Pediatr Transplant; 2005 Feb; 9(1):94-6. PubMed ID: 15667619
[TBL] [Abstract][Full Text] [Related]
4. Rituximab-induced acute thrombocytopenia: a report of two cases.
Otrock ZK; Mahfouz RA; Oghlakian GO; Salem ZM; Bazarbachi A
Haematologica; 2005 Nov; 90 Suppl():ECR23. PubMed ID: 16266914
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency.
Kim JJ; Thrasher AJ; Jones AM; Davies EG; Cale CM
Br J Haematol; 2007 Jul; 138(1):94-6. PubMed ID: 17498197
[TBL] [Abstract][Full Text] [Related]
6. Rituximab-induced severe acute thrombocytopenia: a case report and review of literature.
Dhand S; Bahrain H
Cancer Invest; 2008 Nov; 26(9):913-5. PubMed ID: 19034773
[TBL] [Abstract][Full Text] [Related]
7. Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon.
Ram R; Bonstein L; Gafter-Gvili A; Ben-Bassat I; Shpilberg O; Raanani P
Am J Hematol; 2009 Apr; 84(4):247-50. PubMed ID: 19260124
[TBL] [Abstract][Full Text] [Related]
8. Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment.
Wang J; Wiley JM; Luddy R; Greenberg J; Feuerstein MA; Bussel JB
J Pediatr; 2005 Feb; 146(2):217-21. PubMed ID: 15689912
[TBL] [Abstract][Full Text] [Related]
9. Late-onset neutropenia following viral bone marrow depression after rituximab therapy.
Christopeit M; Haak U; Behre G
Ann Hematol; 2008 Sep; 87(9):761-2. PubMed ID: 18350295
[No Abstract] [Full Text] [Related]
10. [Serum sickness induced by rituximab infusion; report of two cases with hematological malignancies].
Matsui T; Hidaka M; Kawakita T; Inoue Y; Sakai T; Harada N; Takemoto S; Nagakura S; Tsukamoto A; Kiyokawa T; Kawano F
Rinsho Ketsueki; 2009 Apr; 50(4):304-8. PubMed ID: 19404025
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
El-Hallak M; Binstadt BA; Leichtner AM; Bennett CM; Neufeld EJ; Fuhlbrigge RC; Zurakowski D; Sundel RP
J Pediatr; 2007 Apr; 150(4):376-82. PubMed ID: 17382113
[TBL] [Abstract][Full Text] [Related]
12. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
13. Rituximab-induced acute severe thrombocytopenia.
Parajuli R; Hire E; Shah BK
Br J Haematol; 2010 Jun; 149(6):804. PubMed ID: 20602622
[No Abstract] [Full Text] [Related]
14. Severe thrombocytopenia and fibrinolysis mimicking disseminated intravascular coagulation after rituximab infusion.
Kotsianidis I; Goutzouvelidis A; Anastasiades A; Bouchliou I; Nakou E; Spanoudakis E; Christophoridou AV; Margaritis D; Bourikas G; Tsatalas C
Am J Hematol; 2010 Feb; 85(2):146. PubMed ID: 20052746
[No Abstract] [Full Text] [Related]
15. Persistent antibody depletion after rituximab in three children with autoimmune cytopenias.
Adeli MM; Eichner BH; Thornburg C; Williams L
Pediatr Hematol Oncol; 2009 Nov; 26(8):566-72. PubMed ID: 19954366
[TBL] [Abstract][Full Text] [Related]
16. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology.
Dungarwalla M; Marsh JC; Tooze JA; Lucas G; Ouwehand W; Pettengell R; Dearden CE; Gordon Smith EC; Elebute MO
Ann Hematol; 2007 Mar; 86(3):191-7. PubMed ID: 17123083
[TBL] [Abstract][Full Text] [Related]
17. Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments.
Cattaneo C; Spedini P; Casari S; Re A; Tucci A; Borlenghi E; Ungari M; Ruggeri G; Rossi G
Leuk Lymphoma; 2006 Jun; 47(6):1013-7. PubMed ID: 16840190
[TBL] [Abstract][Full Text] [Related]
18. Case report of rituximab-induced thrombocytopenia.
Shah C; Grethlein SJ
Am J Hematol; 2004 Apr; 75(4):263. PubMed ID: 15054827
[No Abstract] [Full Text] [Related]
19. Rituximab-induced acute thrombocytopenia in a patient with prolymphocytic leukemia.
Pamuk GE; Donmez S; Turgut B; Demir M; Vural O
Am J Hematol; 2005 Jan; 78(1):81. PubMed ID: 15609288
[No Abstract] [Full Text] [Related]
20. Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma.
Biehn SE; Kirk D; Rivera MP; Martinez AE; Khandani AH; Orlowski RZ
Hematol Oncol; 2006 Dec; 24(4):234-7. PubMed ID: 16948177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
